CN1056301C - 'Lanweiling' oral liquid for treating appendicitis - Google Patents
'Lanweiling' oral liquid for treating appendicitis Download PDFInfo
- Publication number
- CN1056301C CN1056301C CN97107827A CN97107827A CN1056301C CN 1056301 C CN1056301 C CN 1056301C CN 97107827 A CN97107827 A CN 97107827A CN 97107827 A CN97107827 A CN 97107827A CN 1056301 C CN1056301 C CN 1056301C
- Authority
- CN
- China
- Prior art keywords
- portions
- present
- parts
- lanweiling
- appendicitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Zeng's Lanweiling oral administration liquid for treating appendicitis. The present invention is characterized in that the effective components (by weight ratio) of the present invention are composed of 5 portions of traditional Chinese medicine crude flos lonicerae, 5 portions of forsythiae, 5 portions of dandelion, 5 portions of patrinia, 1 to 2 portions of cortex moutan, 1 to 2 portions of rhubarb, 3 to 5 portions of sargentgloryvine stem, 3 to 5 portions of baical skullcap root, 1 portion of coptis, 3 to 5 portions of red sange root, 3 portions of curcuma root, and 5 portions of corydalis tuber. The Zeng's Lanweiling oral administration liquid for treating appendicitis, which is supplied by the present invention, has the effects of heat clearing, toxic removal, smoothness, blood circulation activation, stasis dissipation, qi promoting and pain relief. The present invention can effectively cure acute appendicitis. The present invention can reduce the operation pain of a patient and can greatly save the outlay of the patient.
Description
The present invention relates to a kind of Chinese patent medicine.
Acute appendicitis is a kind of common surgical diseases.The normal surgical operation therapy that changes after acute appendicitis is made a definite diagnosis, patient should bear the misery of operation, and expense is also higher simultaneously, in the place of no surgical conditions such as rural area, also is easy to cause the delay of the state of an illness.If can utilize the Drug therapy acute appendicitis, then can address the above problem.The Chinese invention patent application discloses the typhlitic Chinese medicine for oral administration of a kind of radical cure for No. 95105963.7, this Chinese medicine is made up of six kinds of medicines such as Radix Et Rhizoma Rhei, Semen Persicae (parched), Spina Gleditsiae, Squama Manis (processed), Semen Coicis, Myrrha (parched), and it is said has effect preferably to treatment appendicitis.
The purpose of this invention is to provide another kind of novel appendicitis medicine (Ceng Shi ' Lanweiling ' oral liquid for treating appendicitis).
The present invention is the typhlitic oral liquid of a kind of treatment, and its active ingredient is to be made by the raw material of following weight portion: 5 parts of 5 parts of Flos Lonicerae, 5 parts of Fructus Forsythiaes, 5 parts of Herba Taraxacis, 5 parts of Herba Patriniae, 1～2 part of Cortex Moutan, 1～2 part of Radix Et Rhizoma Rhei, 3～5 parts of Caulis Sargentodoxaes, 3～5 parts of Radix Scutellariaes, 1 part of Rhizoma Coptidis, 3～5 parts of Radix Salviae Miltiorrhizae, 3 parts of Radix Curcumaes and Rhizoma Corydalis.In the present invention, usually can be by above-mentioned each medicament mixed is decocted, concentrates, bottles and make water preparation.In the finished product of making, except that containing above-mentioned active ingredient, can also increase sugared agent, in order to auxiliary compositions such as antiseptical antiseptic in order to seasoning.
Show that through practical application oral liquid provided by the invention has that heat-clearing and toxic substances removing, Tongli are captured, the effect of blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, can cure acute appendicitis effectively.During treatment, general medication 5～7 days, the healing expense is no more than 100 yuan of RMB, only occupies 1/10 of institute's surgical operation expense.Like this, both reduce the corrective surgery misery, saved its funds spending again greatly.
Content of the present invention further illustrates with the following Examples, but content of the present invention is not limited only to content related among the embodiment.
Embodiment 1:
Take the Chinese medicine crude drug by following prescription:
Flos Lonicerae 5kg, Fructus Forsythiae 5kg, Herba Taraxaci 5kg, Herba Patriniae 5kg, Cortex Moutan 2kg, Radix Et Rhizoma Rhei 1kg, Caulis Sargentodoxae 5kg, Radix Scutellariae 3kg, Rhizoma Coptidis 1kg, Radix Salviae Miltiorrhizae 4kg, Radix Curcumae 3kg, Rhizoma Corydalis 5kg.
Above-mentioned Chinese crude drug is cleaned, dries, be crushed to 20～50 orders again.Medical material after pulverizing is inserted in the pot, add water logging and cross powder, boiled 2 hours, leach medicinal liquid, discard medicinal residues.With filter medicinal liquid be concentrated into 1/2 of stock solution, add ethanol in 1: 1 ratio again, make the float in the medicinal liquid generate precipitation.Filter clear liquid, with the way of distillation ethanol in the clear liquid is reclaimed.The concentration of allotment clear liquid makes every milliliter of clear liquid contain crude drug in whole 1.5 grams, gets 29.3 liters of finished product medicinal liquids at last.
With pack into glass bottle and sterilize, seal of finished product medicinal liquid, promptly make the final finished of water preparation form.
Embodiment 2:
Take the Chinese medicine crude drug by following prescription:
Flos Lonicerae 5kg, Fructus Forsythiae 5kg, Herba Taraxaci 5kg, Herba Patriniae 5kg, Cortex Moutan 1kg, Radix Et Rhizoma Rhei 2kg, Caulis Sargentodoxae 3kg, Radix Scutellariae 5kg, Rhizoma Coptidis 1kg, Radix Salviae Miltiorrhizae 5kg, Radix Curcumae 3kg, Rhizoma Corydalis 5kg.
Similar with last example, the Chinese crude drug of taking is cleaned, is crushed to 20～50 orders again after the oven dry.Medical material after pulverizing is inserted in the pot, add water logging and cross powder, boiled 2 hours, leach medicinal liquid, discard medicinal residues.With filter medicinal liquid be concentrated into 1/2 of stock solution, add ethanol in 1: 1 ratio again, make float generate precipitation.Leach the clear liquid on medicinal liquid top, the ethanol in the clear liquid is reclaimed with the way of distillation.The concentration of allotment clear liquid makes every milliliter of clear liquid contain crude drug in whole 1.5 grams, gets 30 liters of finished product medicinal liquids at last.
With pack into glass bottle and sterilize, seal of finished product medicinal liquid, promptly make the final finished of water preparation form.
By Chengdu University of Traditional Chinese Medicine's Experimental Animal Center experimental determination, the oral liquid of producing in the foregoing description is studied through acute toxicity test in mice, the result shows to mice lavage with Cmax, maximum volume administration three times on the one and a twice-daily, observe that mice does not have death and other anomaly in 7 days, the maximum tolerated dose of this medicine is 434.3g (crude drug)/kg and 289.6 (crude drug)/kg, is respectively 144 times and 96 times of Coming-of-Age Day consumption.More than two treated animals, after administration is observed 7, mice is taken off vertebra and puts to death, dissect mice, the important internal organs of perusal mice comprise the heart, liver, spleen, lung, kidney etc., there is no obvious pathological change.Final conclusion: this oral liquid toxicity is very little, is safety.
Claims (1)
1, the typhlitic oral liquid of a kind of treatment is characterized in that its active ingredient is to be made by the raw material of following weight portion: 5 parts of 5 parts of Flos Lonicerae, 5 parts of Fructus Forsythiaes, 5 parts of Herba Taraxacis, 5 parts of Herba Patriniae, 1～2 part of Cortex Moutan, 1～2 part of Radix Et Rhizoma Rhei, 3～5 parts of Caulis Sargentodoxaes, 3～5 parts of Radix Scutellariaes, 1 part of Rhizoma Coptidis, 3～5 parts of Radix Salviae Miltiorrhizae, 3 parts of Radix Curcumaes and Rhizoma Corydalis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97107827A CN1056301C (en) | 1997-12-16 | 1997-12-16 | 'Lanweiling' oral liquid for treating appendicitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97107827A CN1056301C (en) | 1997-12-16 | 1997-12-16 | 'Lanweiling' oral liquid for treating appendicitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1188658A CN1188658A (en) | 1998-07-29 |
| CN1056301C true CN1056301C (en) | 2000-09-13 |
Family
ID=5169912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97107827A Expired - Fee Related CN1056301C (en) | 1997-12-16 | 1997-12-16 | 'Lanweiling' oral liquid for treating appendicitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1056301C (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1094061C (en) * | 1999-12-24 | 2002-11-13 | 冯俊明 | Medicine for curing appendicitis and its preparing method |
| CN100374144C (en) * | 2006-05-23 | 2008-03-12 | 冯传宝 | Chinese medicinal oral liquid for treating appendicitis and enteritis |
| CN101530516B (en) * | 2009-04-22 | 2011-08-17 | 王永 | Chinese medicament for treating appendicitis |
| CN104189433A (en) * | 2014-09-24 | 2014-12-10 | 吕建晓 | Traditional Chinese medicine preparation for chronic appendicitis and preparation method of traditional Chinese medicine preparation |
| CN105412266A (en) * | 2015-12-21 | 2016-03-23 | 张敬 | Traditional Chinese medicine composition for treating child appendicitis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1115669A (en) * | 1995-06-05 | 1996-01-31 | 张清智 | Orally-taken Chinese medicine for curing appendicitis |
| CN1134831A (en) * | 1995-06-06 | 1996-11-06 | 谭少奇 | Composite pharmaceutics made of oldenlandia and usage thereof |
-
1997
- 1997-12-16 CN CN97107827A patent/CN1056301C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1115669A (en) * | 1995-06-05 | 1996-01-31 | 张清智 | Orally-taken Chinese medicine for curing appendicitis |
| CN1134831A (en) * | 1995-06-06 | 1996-11-06 | 谭少奇 | Composite pharmaceutics made of oldenlandia and usage thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1188658A (en) | 1998-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101062372A (en) | Chinese herbal medicine preparation for dissolving hepatobiliary system calculi | |
| CN111249390A (en) | Forsythia-astragalus root compound preparation and preparation method and application thereof | |
| CN102100872A (en) | Chinese medicine preparation for treating mastitis | |
| CN1056301C (en) | 'Lanweiling' oral liquid for treating appendicitis | |
| CN112755140A (en) | Pharmaceutical composition for treating gouty arthritis and preparation method and application thereof | |
| CN103638190A (en) | Traditional Chinese medicine for treating acute cholecystitis | |
| CN1177599C (en) | Chinese medicine for treating burn and scald and its preparing process | |
| CN102657795A (en) | Traditional Chinese medicine preparation for promoting postoperative incision healing | |
| CN100579544C (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
| CN1063088C (en) | Medicine for curing hepatic and gallbladder diseases | |
| CN105963635A (en) | Traditional Chinese medicinal composition for treating headache | |
| CN102018912A (en) | Chinese herbal preparation for treating acute mastitis | |
| CN100346821C (en) | Medicinal capsule for treating liver and gallbladder diseases and its preparing process | |
| CN1088593C (en) | Quick-acting Chinese medicine for treating cirrhosis and its preparing process | |
| CN108498696A (en) | It is a kind of to be used to treat chill pain in waist and lower extremities, the vina preparation process of muscles and bones numbness | |
| CN108743894A (en) | A kind of children's cold extermination Johnson & Johnson therapeutic massage cream and its processing technology | |
| CN100344305C (en) | Pure traditional Chinese medicine prepn. for treating male sterility, and its prepn. method | |
| CN108159389A (en) | One kind is used to treat prostatitic Chinese medicine composition and preparation method thereof | |
| CN1188162C (en) | Method for preparing Gongjinle medicinal liquor for treating tracheitis | |
| CN105641168A (en) | Medicine for treating viral hepatitis B and viral hepatitis C and preparation method of medicine | |
| CN111494598A (en) | Oral and external traditional Chinese medicine for treating liver-stagnation and spleen-deficiency type acne and preparation method thereof | |
| CN1318402A (en) | Medicine for traumatic fracture pain | |
| CN117838816A (en) | Traditional Chinese medicine compound composition for treating chronic cholecystitis and preparation method and application thereof | |
| CN108635459A (en) | A kind of Chinese medicine acute mastitis cream that treating mastosis and its processing technology | |
| CN116672428A (en) | Traditional Chinese medicine composition for treating wind-cold osteodynia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |